MiMedx Group, Inc short interest in 2023
In 2023, MiMedx Group, Inc's disclosed short interest ran from 2.52% of shares outstanding on 13 Jan 2023 to 3.41% on 29 Dec 2023, a change of +0.89 percentage points. The year's high was 4.06% on 13 Oct 2023 and its low 2.52% on 13 Jan 2023, averaging 3.11% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.36 days on 28 Apr 2023. Full history: MiMedx Group, Inc.
Cite this page
By year: 2018 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 2.52% (13 Jan 2023)
- End of year
- 3.41% (29 Dec 2023)
- Change
- +0.89 pp
- High
- 4.06% (13 Oct 2023)
- Low
- 2.52% (13 Jan 2023)
- Average
- 3.11%
- Highest days to cover
- 10.36 (28 Apr 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 2.52% | 4.90 | results (8-K) |
| 31 Jan 2023 | 2.52% | 5.05 | |
| 15 Feb 2023 | 2.69% | 5.19 | |
| 28 Feb 2023 | 2.76% | 6.78 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 2.90% | 5.08 | |
| 31 Mar 2023 | 2.97% | 6.03 | |
| 14 Apr 2023 | 2.83% | 8.48 | |
| 28 Apr 2023 | 2.91% | 10.36 | |
| 15 May 2023 | 3.02% | 3.07 | 10-Q filed, results (8-K) |
| 31 May 2023 | 3.01% | 5.90 | |
| 15 Jun 2023 | 2.93% | 4.71 | |
| 30 Jun 2023 | 2.88% | 2.40 | |
| 14 Jul 2023 | 2.90% | 5.73 | |
| 31 Jul 2023 | 2.91% | 3.71 | |
| 15 Aug 2023 | 2.72% | 3.54 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 2.80% | 6.29 | |
| 15 Sep 2023 | 3.10% | 5.06 | |
| 29 Sep 2023 | 4.00% | 7.97 | |
| 13 Oct 2023 | 4.06% | 7.69 | |
| 31 Oct 2023 | 4.02% | 9.29 | 10-Q filed, results (8-K) |
| 15 Nov 2023 | 3.53% | 5.46 | |
| 30 Nov 2023 | 3.69% | 7.16 | |
| 15 Dec 2023 | 3.65% | 5.12 | |
| 29 Dec 2023 | 3.41% | 6.58 |
See also: MiMedx Group, Inc's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.